Mid-single-digit domestic M&HCV industry growth in FY26
Management expects mid-single-digit growth for M&HCV and slightly higher for LCV, with H2 likely stronger due to low base and improving macro.
Ashok Leyland · forward-looking guidance across the available source record.
Guidance tracker
Management expects mid-single-digit growth for M&HCV and slightly higher for LCV, with H2 likely stronger due to low base and improving macro.
Strong order book (₹1,000+ crore) and tender pipeline (₹2,000+ crore) support double-digit defense revenue growth for the full year.
Switch India achieved PBT breakeven in Q1; management targets EBITDA-positive status for the full year.
Current capacity of 950 buses/month to be expanded to 1,650, including the new Lucknow plant operational from Q3 FY26.
Management expects the replacement cycle triggered by GST to sustain, with bulk buyers now joining retail buyers. FY27 should see good volume growth, though H1 may have a low base and H2 a high base.
Management has started reducing discounts to recover ~60 bps of commodity cost impact, with further price increases possible if pressure persists.
Switch India (EV subsidiary) is on track to achieve free cash flow positivity by FY27, with current order book of 1,350 units and positive EBITDA/PAT.
Management sees no need for significant capacity expansion; only niche investments of ₹50-100 crore may be required.
Capital expenditure for FY27 is planned at ₹750-1,000 crore, focused on new products and alternate powertrain technologies.
A price increase of 1-1.5% was taken from April 1, 2026, to partially offset commodity cost inflation.
Construction of the battery pack facility at Pille Pakam will begin in 8-10 weeks, with production start targeted for Q2 FY27.
Management expects defense revenue to maintain ~20% growth trajectory, supported by a strong order book and pipeline.